ニュース

The market appears to be short-sighted.

Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.

The Federal Reserve and banking regulations can have big impacts on profitability for these banking giants.

A number of stocks fell in the afternoon session after long-dated Treasury yields pushed to fresh highs, with the 30-year nearing 5.18% and the 10-year hovering around 4.6%.

The latest reported delays follow the group’s decision last year to put off the launch of a freighter version of the A350 due to broader supply chain disruption.

Founded five years ago, Exa has developed a search engine aimed at providing comprehensive information retrieval for AI applications.

Palo Alto Networks recently launched Idira, an identity security platform that unifies discovery, control and governance for human, machine and AI identities, aiming to replace traditional privilege access management with AI-driven visibility, dynamic controls and zero standing privilege. A key feature of Idira is its ability to extend modern privilege controls to existing CyberArk customers across SaaS tiers, positioning Palo Alto Networks to address the rapidly growing volume of non-human...

Meta Platforms is cutting roughly 8,000 jobs and reassigning about 7,000 employees into newly formed AI focused teams. The company is rolling out an AI first restructuring that includes keystroke and mouse tracking tools used for AI training. Employees are pushing back over monitoring, morale and privacy, while regulators and workforce advocates scrutinize the changes. For investors watching NasdaqGS:META, these internal shifts sit alongside a share price of $605.06 and a mixed recent...

On May 15, 2026, ExxonMobil criticized ISS’s recommendation against its Texas redomiciliation proposal, arguing ISS used flawed analysis, misstated shareholder protections, and failed to disclose a conflict of interest linked to ongoing litigation. ExxonMobil’s pushback highlights how corporate governance structures, legal forums, and retail voting programs can materially influence shareholder rights and long-term corporate oversight. We’ll now explore how the fraud-case clearance and...

C3.ai's founder just returned to his role as chief executive officer.

Wondering if Palantir Technologies at US$137.15 is still offering value, or if most of the upside is already priced in? This article walks through the key numbers so you can judge for yourself. The stock is up 5.5% over the last week, but down 6.0% over the last month and down 18.3% year to date, while the 1 year return is 13.7% and the 3 year return is very large. Recent headlines have focused on Palantir's role in artificial intelligence and government data contracts, with investors...

Equitable Holdings is under fresh review as analysts adjust their price targets, with several firms trimming their estimates by about US$1 to US$8 while others edge theirs higher. These changes reflect a split view, where some analysts point to earnings power and capital returns as support for current valuations, while others stress execution risk and less room for upside surprise across life and annuity stocks. As you read on, you will see how to track these shifting calls and what they...

Microsoft (NasdaqGS:MSFT) and OneStream have agreed to expand their AI partnership to embed finance-focused AI agents and infrastructure into Microsoft 365 Copilot and Azure. The collaboration centers on integrating OneStream’s SensibleAI agents and quantitative AI forecasting into everyday Microsoft finance workflows. The goal is to support AI driven forecasting, anomaly detection, and natural language queries for finance teams directly inside familiar Microsoft tools. For investors...

(Updates with YouTube and TikTok's responses in the fifth and sixth paragraphs, respectively.) Al

Vertex Pharmaceuticals (VRTX) stock has moved lower recently, with the price down about 2% over the past month and roughly 8% over the past 3 months, prompting closer attention from investors. See our latest analysis for Vertex Pharmaceuticals. Zooming out, Vertex’s recent share price weakness, including a 1-day share price return of down 0.89% and a 7-day share price return of down 4.99%, sits against a 5-year total shareholder return of 108.14%. This points to fading short term momentum...

A handful of quantum-computing companies have been given grants that include U.S. government equity stakes, sending their shares higher in premarket trading: IBM is getting $1 billion of the $2 billion total package.

Fluor (NYSE:FLR) has been selected by Anglo American for a feasibility study on the Woodsmith mining project. The contract focuses on progressing a major greenfield asset with low carbon objectives. This award adds to Fluor's portfolio in the mining and resources sector. For you as an investor, this new feasibility study adds fresh context to Fluor's role in large resource projects. The company offers engineering, procurement and construction services across energy, infrastructure and...

UiPath (NYSE:PATH) has announced the passing of board member S. "Soma" Somasegar. Somasegar joined the board in September 2024 and served on the Nominating and Corporate Governance Committee. His death represents a change in the boardroom that matters for UiPath’s governance structure. For investors tracking UiPath, this leadership change comes with the stock recently trading at $10.77. Shares have risen 13.7% over the past week and 2.0% over the past month, while the stock is down 32.2%...

The smart money read on Wells Fargo (NYSE: WFC) following the $110 million lending and hiring discrimination settlement approved by a federal judge is clearly constructive. Sell-side analysts carry a buy-skewed consensus and a 12-month price target well above where shares trade today, while insiders have been net buyers into the settlement window. The Hard ... Wall Street’s Verdict on Wells Fargo After the $110 Million Discrimination Settlement

Deere (DE) delivered earnings and revenue surprises of +12.74% and +2.98%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

An investigational drug developed by Eli Lilly delivered clinically meaningful weight loss in a trial, the company said as it looks expand its obesity treatment portfolio amid soaring demand.

Wall Street futures pointed moderately lower pre-bell Thursday as traders again weighed the odds of

A number of stocks fell in the afternoon session after long-dated Treasury yields pushed to fresh highs, with the 30-year nearing 5.18% and the 10-year hovering around 4.6%.

Walmart delivered another quarter of impressive sales as speedy deliveries and low prices served as a magnet for shoppers across the income spectrum. Walmart has resonated with many Americans who are increasingly careful about where they spend their money as inflation has taken a bigger bite out of paychecks, particularly since the start of the Iran war in late February. Traffic at Walmart can be a barometer of consumer spending given its vast customer base.

Fed meeting minutes show officials won’t rule out rate hikes, Target’s turnaround is underway, OpenAI prepping IPO filing, and more news to start your day.

Ehrenp ent Tesla SpaceX reviewed his Tesla ties reis Director investor before ​determining he met Nasdaq since and independence standards. February director Expected to ‌chair SpaceX's 2026 Compensation and Nominating Committee post-IPO. Randy Independ Co-found Served as a SpaceX board observer Glein ent er of for more than 16 years before Director DFJ formally joining the board.

IBM says it plans to create ‘America’s first pure-play quantum foundry’ in collaboration with the Commerce Department.